Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

BeOne Medicines Ltd. - Sponsored ADR  (ONC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
BeOne Medicines Ltd. - Sponsored ADR (ONC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended September 2025, BeOne Medicines Ltd. - Sponsored ADR (ONC) reported revenue of $1.41 billion, up 41% over the same period last year. EPS came in at $1.09, compared to -$1.15

Ovintiv Q3 Earnings Surpass Estimates, Revenues Decline Y/Y
Ovintiv Q3 Earnings Surpass Estimates, Revenues Decline Y/Y

Ovintiv Inc. OVV reported third-quarter 2025 adjusted earnings per share of $1.03, which beat the Zacks Consensus Estimate of 97 cents. The outperformance was driven by higher plant condensate

ACAD Q3 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue GrowthPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
ACAD Q3 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth

Acadia Pharmaceuticals ACAD reported third-quarter 2025 earnings of 26 cents per share (excluding a one-time tax benefit), which beat the Zacks Consensus Estimate of 14 cents. In the year-ago

Evergy's Q3 Earnings & Revenues Lag Estimates, '25 EPS View Narrowed
Evergy's Q3 Earnings & Revenues Lag Estimates, '25 EPS View Narrowed

Evergy, Inc. EVRG reported third-quarter 2025 operating earnings per share (EPS) of $2.03 per share, which missed the Zacks Consensus Estimate of $2.14 by 5.1%. In the year-ago quarter, the company

TEVA Q3 Earnings & Revenues Beat, Austedo Sales View Raised, Stock UpPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
TEVA Q3 Earnings & Revenues Beat, Austedo Sales View Raised, Stock Up

Teva Pharmaceutical Industries TEVA reported third-quarter 2025 adjusted earnings of 78 cents per share, which beat the Zacks Consensus Estimate of 68 cents. Adjusted earnings rose 14% year over

Murphy Oil Q3 Earnings & Sales Beat Estimates, New Wells Boost VolumesPhoto, wide shot, wide-angle lens,  Gas company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/01083d82-021d-4573-8c40-0e836a0771d6.png
Murphy Oil Q3 Earnings & Sales Beat Estimates, New Wells Boost Volumes

Murphy Oil Corporation MUR delivered third-quarter 2025 adjusted net earnings of 41 cents per share, which beat the Zacks Consensus Estimate of 16 cents by 156.3%. However, the bottom line decreased

Earnings Data Deluge
Earnings Data Deluge

Pre-market indexes are bounding into positive territory at this hour, after wallowing in the red following yesterday’s solid gains. One might say the relative volatility we started seeing in early

Top Wind Energy Stocks to Add to Your Portfolio for Long-Term Growth
Top Wind Energy Stocks to Add to Your Portfolio for Long-Term Growth

An updated edition of the Sept. 15, 2025 article.The transition toward renewable energy continues to gain momentum as global efforts to minimize greenhouse gas emissions intensify. Among various

IonQ's Q3 Loss Widens but Solid Quantum Roadmap Drives Stock
IonQ's Q3 Loss Widens but Solid Quantum Roadmap Drives Stock

IonQ’s IONQ bottom line weakened significantly on a GAAP basis in the third quarter of 2025. The company reported a GAAP net loss of $3.58 per share, much wider than the Zacks Consensus Estimate of

Energy Transfer Q3 Earnings Lag Estimates, Revenues Decline Y/Y
Energy Transfer Q3 Earnings Lag Estimates, Revenues Decline Y/Y

Energy Transfer ET reported third-quarter 2025 adjusted earnings of 28 cents per unit, which missed the Zacks Consensus Estimate of 33 cents by 15.2%. The bottom line also decreased 12.5% from the

Do Options Traders Know Something About CarGurus Stock We Don't?
Do Options Traders Know Something About CarGurus Stock We Don't?

Investors in CarGurus, Inc. CARG need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $20 Put had some of the highest implied

Interparfums Q3 Earnings Beat Estimates, 2025 Guidance Lowered
Interparfums Q3 Earnings Beat Estimates, 2025 Guidance Lowered

Interparfums, Inc. (IPAR) reported third-quarter 2025 results, wherein the bottom line beat the Zacks Consensus Estimate. Both earnings and sales increased year over year.

Management highlighted

Are Options Traders Betting on a Big Move in First Busey Stock?
Are Options Traders Betting on a Big Move in First Busey Stock?

Investors in First Busey Corporation BUSE need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 21, 2025 $10 Call had some of the highest

Implied Volatility Surging for Array Technologies Stock Options
Implied Volatility Surging for Array Technologies Stock Options

Investors in Array Technologies, Inc. ARRY need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 21, 2025 $1.00 Call had some of the highest

Compared to Estimates, EchoStar (SATS) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, EchoStar (SATS) Q3 Earnings: A Look at Key Metrics

EchoStar (SATS) reported $3.61 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 7.1%. EPS of $0.83 for the same period compares to -$0.52 a year ago.

Melco (MLCO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Melco (MLCO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Melco Resorts (MLCO) reported revenue of $1.31 billion, up 11.4% over the same period last year. EPS came in at $0.21, compared to $0.08 in the year-ago

Compared to Estimates, Altice USA (ATUS) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Altice USA (ATUS) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, Altice USA, Inc. (ATUS) reported revenue of $2.11 billion, down 5.4% over the same period last year. EPS came in at -$0.12, compared to -$0.09 in the year-ago

Constellation Energy to Report Q3 Earnings: How to Play the Stock?
Constellation Energy to Report Q3 Earnings: How to Play the Stock?

Constellation Energy Corporation CEG is expected to report third-quarter 2025 earnings on Nov. 7, before market open. The Zacks Consensus Estimate for revenues is pinned at $6.12 billion, indicating

Southwest Gas Q3 Earnings Miss Estimates, Revenues Decrease Y/Y
Southwest Gas Q3 Earnings Miss Estimates, Revenues Decrease Y/Y

Southwest Gas Holdings Inc. SWX recorded third-quarter 2025 operating earnings of 6 cents per share, which missed the Zacks Consensus Estimate of 9 cents by 33.3%. The bottom line also decreased

Devon Q3 Earnings & Sales Beat Estimates on Strong Production Volumes
Devon Q3 Earnings & Sales Beat Estimates on Strong Production Volumes

Devon Energy Corp. DVN reported third-quarter 2025 earnings per share (EPS) of $1.04, beating the Zacks Consensus Estimate of 93 cents by 11.8%. The third-quarter earnings were down 5.5% year over

Do Options Traders Know Something About Ally Financial Stock We Don't?
Do Options Traders Know Something About Ally Financial Stock We Don't?

Investors in Ally Financial Inc. ALLY need to pay close attention to the stock based on moves in the options market lately. That is because the Nov. 21, 2025 $19.00 Put had some of the highest

JAZZ Beats on Q3 Earnings & Sales, Narrows '25 Sales ViewPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
JAZZ Beats on Q3 Earnings & Sales, Narrows '25 Sales View

Jazz Pharmaceuticals JAZZ reported third-quarter 2025 adjusted earnings per share (EPS) of $8.13 per share, beating the Zacks Consensus Estimate of $5.74. This beat was largely due to an income tax

Rivian Q3 Earnings Beat Expectations, Revenues Increase Y/YPhoto, wide shot, wide-angle lens, soft focus,  Auto parts supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-XjwbnkgTrFCFx6Y3gLbqZBCj.png?st=2023-05-13T09%3A21%3A52Z&se=2023-05-13T11%3A21%3A52Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-13T06%3A55%3A39Z&ske=2023-05-14T06%3A55%3A39Z&sks=b&skv=2021-08-06&sig=wJlbn/o%2BieTjclaQNRsJc%2BDDZieC0UCS6BPi5tapxAA%3D
Rivian Q3 Earnings Beat Expectations, Revenues Increase Y/Y

Rivian Automotive RIVN incurred a loss of 70 cents per share in the third quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 72 cents and the year-ago period’s loss of $1.03

Catalyst Pharmaceuticals Q3 Earnings Beat, Firdapse Revenues Rise Y/YPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Catalyst Pharmaceuticals Q3 Earnings Beat, Firdapse Revenues Rise Y/Y

Catalyst Pharmaceuticals CPRX reported adjusted earnings of 68 cents per share for the third quarter of 2025, beating the Zacks Consensus Estimate of 51 cents. The company had recorded adjusted

York Water (YORW) Q3 Earnings Top Estimates
York Water (YORW) Q3 Earnings Top Estimates

York Water (YORW) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.41 per share a year ago. These figures